Chugai Pharmaceutical (TYO:4519) reported a 31% increase in net income to 97.2 billion yen for the three months ended March 31, from 74.4 billion yen a year ago.
The pharmaceutical group's earnings per share rose to 59.08 yen from 45.21 yen a year ago, according to a Thursday bourse filing.
Revenue jumped 22% to 288.5 billion yen from 236.9 billion yen a year earlier.
For the year ending Dec. 31, the company expects core net income to increase 3.2% to 410.0 billion yen or 250.00 yen per share, while revenue is projected to rise 1.7% to 1.19 trillion yen.
The company plans to pay interim and year-end dividends of 125.00 yen per share each, including a special dividend for its 100th anniversary, totaling 250.00 yen per share for the fiscal year.
Price (JPY): $8285.00, Change: $+34, Percent Change: +0.41%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。